Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Simona Rodighiero"'
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 6, Pp n/a-n/a (2023)
Abstract MYC is a key oncogenic driver in multiple tumor types, but concomitantly endows cancer cells with a series of vulnerabilities that provide opportunities for targeted pharmacological intervention. For example, drugs that suppress mitochondria
Externí odkaz:
https://doaj.org/article/dd1aad8474044a6a872abca328cab2af
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
Autor:
Giulio Donati, Micol Ravà, Marco Filipuzzi, Paola Nicoli, Laura Cassina, Alessandro Verrecchia, Mirko Doni, Simona Rodighiero, Federica Parodi, Alessandra Boletta, Christopher P. Vellano, Joseph R. Marszalek, Giulio F. Draetta, Bruno Amati
Publikováno v:
Molecular Oncology, Vol 16, Iss 5, Pp 1132-1152 (2022)
Multiple molecular features, such as activation of specific oncogenes (e.g., MYC, BCL2) or a variety of gene expression signatures, have been associated with disease course in diffuse large B‐cell lymphoma (DLBCL), although their relationships and
Externí odkaz:
https://doaj.org/article/25494cefbbb1465b908303161ee213bd
Autor:
Bruno A Duso, Elena Gavilán Dorronzoro, Giulia Tini, Maria R de Filippo, Emanuele Bonetti, Maria R Ippolito, Chiara Soriani, Paolo D'Amico, Simona Rodighiero, Giuseppe Curigliano, Stefano Santaguida, Massimo Cristofanilli, Pier Giuseppe Pelicci, Luca Mazzarella
Publikováno v:
Cancer Research. 82:P5-13
Background: Despite major technological and conceptual advancements, treatment decisions in HER2+ metastatic breast cancer (mBC) remain largely based on clinical evidence, with no established predictive biomarkers to direct treatment for individual p
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
Publikováno v:
EMBO Molecular Medicine.
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
Autor:
Federica Parodi, Alessandra Boletta, Giulio Donati, Bruno Amati, Christopher P. Vellano, Giulio Draetta, Micol Ravà, Joseph R. Marszalek, Alessandro Verrecchia, Paola Nicoli, Mirko Doni, Simona Rodighiero, Marco Filipuzzi, Laura Cassina
Publikováno v:
Molecular Oncology. 16:1132-1152
Multiple molecular features, such as activation of specific oncogenes (e.g., MYC, BCL2) or a variety of gene expression signatures, have been associated with disease course in diffuse large B-cell lymphoma (DLBCL), although their relationships and im
Autor:
Bruno A. Duso, Eleonora Messuti, Emanuele Bonetti, Giulia Tini, Alessia Castiglioni, Giuseppe Ciossani, Silvia Monzani, Chiara Soriani, Simona Rodighiero, Luigi Scietti, Costantino Jemos, Luca Mazzarella
Publikováno v:
Cancer Research. 83:4896-4896
The tumor suppressor NF1 is classically considered a negative RAS regulator, but sparse evidence suggests additional RAS-independent roles. Early studies suggested an interaction with tubulin, which remains poorly characterized to date but may be of
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
MYC is a key oncogenic driver and an adverse prognostic factor in multiple types of cancer, including diffuse large B-cell lymphoma (DLBCL). Yet, MYC activation also endows cancer cells with a series of metabolic dependencies, which can provide strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e075273513e572bfc05f56cd02625742
https://doi.org/10.1101/2022.06.21.497021
https://doi.org/10.1101/2022.06.21.497021
Autor:
Carina B. Nava Lauson, Silvia Tiberti, Paola A. Corsetto, Federica Conte, Punit Tyagi, Markus Machwirth, Stefan Ebert, Alessia Loffreda, Lukas Scheller, Dalia Sheta, Zeinab Mokhtari, Timo Peters, Ayush T. Raman, Francesco Greco, Angela M. Rizzo, Andreas Beilhack, Giovanni Signore, Nicola Tumino, Paola Vacca, Liam A. McDonnell, Andrea Raimondi, Philip D. Greenberg, Johannes B. Huppa, Simone Cardaci, Ignazio Caruana, Simona Rodighiero, Luigi Nezi, Teresa Manzo
Publikováno v:
Cell Metabolism. 35:633-650.e9
Autor:
Bruno Achutti Duso, Elena Gavilan Dorronzoro, Giulia Tini, Maria de Filippo, Marica Ippolito, Chiara Soriani, Simona Rodighiero, Stefano Santaguida, Pier Giuseppe Pelicci, Luca Mazzarella
Publikováno v:
Cancer Research. 82:1164-1164
Background: Centrosome amplification (CA, the presence of >2 centrosomes) is a hallmark of several tumors. CA perturbs mitosis by generating nonphysiological pulling forces, leading to chromosome missegregation and aneuploidy. This condition may be a
Autor:
Simone Tamburri, Eleonora Ponzo, Federico Rossi, Marika Zanotti, Simona Rodighiero, Diego Pasini, Daria Manganaro, Karin Johanna Ferrari, Daniel Fernández-Pérez, Eric Conway
Publikováno v:
Molecular Cell
Summary BAP1 is mutated or deleted in many cancer types, including mesothelioma, uveal melanoma, and cholangiocarcinoma. It is the catalytic subunit of the PR-DUB complex, which removes PRC1-mediated H2AK119ub1, essential for maintaining transcriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed4cfe3006157ef0b911f7e9c253c92
https://hdl.handle.net/2434/946749
https://hdl.handle.net/2434/946749